Semaglutide Weight Management and Cardiovascular Risk Reduction slide image

Semaglutide Weight Management and Cardiovascular Risk Reduction

Agenda Introduction Insulin GLP-1 in diabetes GLP-1 in obesity Q&A Insulin Icodec CagriSema in diabetes Oral semaglutide in diabetes Oral semaglutide in obesity Semaglutide 2.4 mg: STEP HFPEF Daniel Bohsen & Martin Holst Lange Stephen Gough Martin Holst Lange Stephen Gough Stephen Gough Martin Holst Lange All O novo nordisk
View entire presentation